Hot Paths

Lilly halving planned €2.3B investment in Germany (LLY:NYSE)

Lilly Biotechnology Center in San Diego, California, USA.

JHVEPhoto

Eli Lilly (LLY) CEO Dave Ricks told German business daily Handelsblatt that his company will halve its initially planned €2.3B ($2.7B) investment in Germany as the weight-loss drugmaker focuses its home market in the U.S.

The Indiana-based drugmaker has already

Exit mobile version